Updated:
G Square
G Square is a leading healthcare private equity investor focusing on mid-market companies with high growth potential. The firm specialises in the healthcare...
G Square
G Square is a leading healthcare private equity investor focusing on mid-market companies with high growth potential. The firm specialises in the healthcare sector and invests primarily across Europe, partnering with healthcare entrepreneurs and executives. It takes a hands-on approach, working closely with portfolio companies to identify growth opportunities and drive performance improvements.
General information
Firm type
Private Equity
Year founded
2008
Location
Region
Europe
Country
United Kingdom
City
Sao Paulo
Corporate office
London, United Kingdom
Principals
Dr. Laurent Ganem
Founder & CEO
Sector focus
Frequently asked questions
What is G Square's exclusive sector focus?
G Square is a healthcare specialist, targeting buyout and growth-stage investments exclusively within the healthcare sector. The firm backs companies in areas such as healthcare services, pharma services, and medical devices. This narrow focus distinguishes it from generalist mid-market private equity firms.
How does G Square source investment opportunities?
G Square relies on deep sector specialization and established relationships within European healthcare markets to source proprietary deal flow. The firm's team includes operating partners with direct industry experience, which strengthens its network among founders and management teams. This domain-expert reputation often provides earlier and more exclusive deal access.
Does G Square invest outside of Europe?
G Square's geographic focus is concentrated on Western Europe and the United Kingdom. The firm targets healthcare companies within these mature, highly regulated markets, where its local networks and sector expertise are most effective. There is no public record of the firm pursuing investments outside this region.
Who are G Square's primary competitors and co-investors?
G Square competes with other Europe-based healthcare-specialist private equity firms as well as the healthcare teams of large-cap generalist funds. The firm is known to co-invest selectively alongside other sponsors in larger transactions. Specific competitor or co-investor names are not publicly disclosed as part of the firm's standard communications.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: